System and Method for Delivery of Gas to a Tissue
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/939,975, filed Nov 25, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,524,127 | System and Method for Delivery of Gas to a Tissue In force · High confidence | Beyond Air, Inc. | In force | High confidence | ||
| US 11,819,606 | System and Method for Delivery of Gas to a Tissue In force · High confidence | Beyond Air, Inc. | In force | High confidence | ||
| US 12,636,445 | System and Method for Delivery of Gas to a Tissue In force · High confidence | Beyond Air, Inc. | In force | High confidence | ||
| US 12,691,234 | Methods Employing Gaseous Nitric Oxide for Inhibiting Tumor Growth In force · High confidence | Beyond Air, Inc. | In force | High confidence | ||
| Application 19/689,969 | Methods Employing Gaseous Nitric Oxide for Inhibiting Tumor Growth Pending Not granted | Beyond Air, Inc. | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Beyond Air Ltd..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.